Keywords: cytomed, commences, cmi-977, clinical, trials, initiated, its

CytoMed Commences CMI-977 Clinical Trials

Article | 14 May 1998

Print This

CytoMed has initiated clinical trials of CMI-977, its orally-active5-lipoxygenase inhibitor for the treatment of asthma. The drug acts via ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in